GATA6 Expression as a Predictor of Response to Peri-Operative Chemotherapy in Resectable Pancreatic Adenocarcinoma
Clinical trial NCT04472910 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04472910
- Sponsor
- University Health Network, Toronto
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-21
- Primary completion
- 2026-06-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.